TRRAP links Myc with histone acetylases and appears to be an important mediator of its oncogenic function. Here we show that interaction with TRRAP is required for cellular transformation not only by Myc, but also by the adenovirus E1A protein. Substitution of the 262 Nterminal residues of Myc with a small domain of E1A (residues 12 ± 54) restores Myc transforming function. E1A(12 ± 54) contains a TRRAP-interaction domain, that recruits TRRAP to either E1A ± Myc chimeras, or the native 12S E1A protein. Overexpression of a competing TRRAP fragment in vivo blocks interaction of cellular TRRAP with either E1A ± Myc or E1A, and suppresses cellular transformation by both oncoproteins. Moreover, E1A(D26 ± 35) that fails to bind TRRAP but is capable of binding the Retinoblastoma (Rb)-family and p300/CBP proteins is defective in cellular immortalization, transformation and cell cycle deregulation. Thus in addition to disrupting Rb and p300/CBP functions, E1A must recruit TRRAP to transform cells. Oncogene (2001) 20, 8270 ± 8275.
Introduction
Adenovirus E1A and c-Myc oncoproteins exhibit remarkable parallels in their biological activities such as their abilities to transform and immortalize cells, to induce cell cycle progression and apoptosis as well as blocking dierentiation (for reviews see Amati et al., 1998; Dyson and Harlow, 1992; Marcu et al., 1992) . Both proteins apparently act through distinct molecular mechanisms. E1A function is largely mediated through inhibition of the Retinoblastoma (Rb)-family proteins and the transcriptional co-activators p300/ CBP (Whyte et al., 1989) . In contrast, c-Myc is a sequence-speci®c DNA binding protein regulating the transcription of speci®c target genes . The activities of Myc are mediated in part by TRRAP, a protein that binds to a functionally critical region in the c-Myc N-terminus (McMahon et al., 1998) . TRRAP is a subunit of at least two types of histone acetyl-transferase (HAT) complexes, GCN5/ SAGA and Tip60/NuA4 (Brand et al., 1999; Ikura et al., 2000; Vassilev et al., 1998 ; reviewed in Amati et al., 2001) , and provides a physical link between Myc and the HAT subunit GCN5 (McMahon et al., 2000) . Furthermore, Myc recruits TRRAP to its target sites in chromatin and induces localized histone acetylation (Bouchard et al., 2001; Frank et al., 2001) . Altogether, these observations are consistent with a role for TRRAP in the regulation of Myc-target genes.
Expression of a TRRAP fragment can suppress cellular transformation not only by Myc, but also by E1A (McMahon et al., 1998) . Similarly, the Myc Nterminus can suppress transformation by E1A (Brough et al., 1995) . Moreover, the N-terminus of E1A can functionally replace the c-Myc N-terminus to create transformation-competent E1A ± Myc chimeras (Ralston, 1991) , suggesting some commonality of E1A and Myc function at the molecular level. Here we show that similar to c-Myc, E1A binds to TRRAP. We have mapped the domain of E1A that is required for this interaction, and show that it is the same domain that can functionally substitute the Myc N-terminus. Finally, we show that recruitment of TRRAP is required for either E1A or E1A ± Myc chimeras to promote oncogenic transformation.
Results
Small N-terminal domain of E1A can replace the c-Myc N-terminus in cellular transformation
Initially we fused the 120 N-terminal residues of adenovirus 5 E1A to the C-terminus of Myc to generate E1A(1 ± 120) ± Myc(263 ± 439), a chimera highly active in co-operation with activated Ras (see Ralston, 1991 and Figure 1a) . To determine the domains of E1A required for this activity we tested a series of mutant chimeras (Figure 1a ). Figure 1b shows that all proteins were expressed at comparable levels in transfected cells. To our surprise a small region between residues 12 ± 54 of E1A was sucient to generate full transforming activity when fused to the C-terminal domain of c-Myc. In contrast, deletion of either the N-terminal 23 residues, residues 26 ± 35 or residues 38 ± 65 within conserved region 1 (CR1) of E1A abolished transforming activity. The activity of the E1A ± Myc chimeras was severely compromised by mutation of Arginines 364/6/7 of Myc to Alanine, which speci®cally impairs DNA-binding by Myc/Max dimers (Amati et al., 1992) . Thus, cellular transformation by the chimeras is largely dependent on tethering E1A N-terminal sequences to Myc-target sites in DNA (Figure 1a ). In summary, E1A (12 ± 54) is sucient to substitute for the Myc N-terminus (1 ± 262) in cellular transformation.
Residues 12 ± 54 of E1A mediate interaction with TRRAP As interaction of the c-Myc N-terminus with TRRAP appears to be required for cellular transformation by Myc (McMahon et al., 1998), we wondered whether the activity of E1A ± Myc chimeras might also involve interaction with TRRAP. To address this question, we raised antibodies directed against a peptide sequence located in the N-terminal region of TRRAP (TRRAP ± NT). When cells were transfected with plasmids encoding dierent TRRAP fragments, only the N-terminal fragment (T1) was immunoprecipitated by TRRAP ± NT (data not shown). TRRAP ± NT also precipitated endogenous TRRAP and co-precipitated c-Myc from rat embryo ®broblasts (REFs) cotransfected with myc and ras (Figure 2a) . In REFs expressing ras and E1A(12 ± 54) ± Myc, the chimeric protein was co-precipitated by TRRAP ± NT. Both interactions were stable in cell lysates prepared with Tween but did not resist more stringent detergents (RIPA). In contrast, the deletion mutant E1A12 ± 54(D26 ± 35) ± Myc was unable to form stable complexes with TRRAP in cells (Figure 2a) . A deletion in the CR1 region of E1A (aa 38 ± 65) also disabled both transformation ( Figure 1a ) and TRRAP binding ( Figure 2b ). Thus, TRRAP binding correlates with the transforming activity of E1A ± Myc chimeras.
TRRAP recruitment by E1A ± Myc chimeras requires E1A(12 ± 54) and pull-down experiments with sepharose-coupled synthetic E1A(12 ± 54) peptides show that this domain is sucient for TRRAP binding. In contrast, TRRAP/E1A-peptide interaction was lost when residues 26 ± 35 of the E1A(12 ± 54) peptide were scrambled ( Figure 2c ). This suggested that E1A itself might interact with TRRAP via its N-terminal domain. Immunoprecipitation with the TRRAP ± NT antibody from lysates of transfected cells revealed that 12S E1A, but not 12S D26 ± 35, interacts with TRRAP ( Figure 2d ).
Recruitment of TRRAP is required for cellular transformation by E1A ± Myc and E1A
To explore whether TRRAP binding to E1A or E1A ± Myc is relevant for the transforming function of these proteins, we co-transfected these oncogenes into REFs together with Ras and increasing concentrations of overlapping Hae-tagged fragments of TRRAP. Only fragment T3 (aa 1351 ± 2274) was able to suppress the formation of foci by either E1A ± Myc/Ras or E1A/Ras ( Figure 3a , black bars). None of the TRRAP fragments suppressed the formation of puromycin-resistant colonies (empty bars), showing that suppression of focus formation was not due to a general toxic eect of T3. Importantly, suppression of focus formation correlated with a T3-speci®c competition for the binding of endogenous TRRAP to E1A ± Myc or E1A in the same cells (Figure 3b and c, respectively). This indicates that recruitment of TRRAP is required for both E1A ± Myc and E1A transforming activities.
Consistent with an importance of the E1A ± TRRAP interaction for E1A transformation activity, co-transfection of the E1AD26 ± 35 mutant with Ras showed a 90% reduction in focus formation in comparison to the E1A/Ras control (Figure 4a ), although both E1A proteins were expressed at similar levels ( Figure 2d) . Similarly, in the absence of Ras, E1A induced prolonged proliferation (immortalization) of REFs in culture, while E1AD26 ± 35 did not (Figure 4b) . Altogether, our data imply that in addition to interfering with Rb and p300/CBP functions, E1A recruitment of TRRAP is required for full transforming activity.
Our data also suggest that interaction with TRRAP is not the only function provided by E1A to the activity of E1A ± Myc chimeras. Deletion of the 23 Nterminal residues of E1A does not aect TRRAP binding (Figure 2b) . Nevertheless, E1A(24 ± 120) ± Myc is biologically inactive (Figure 1a ). This suggests a role for an additional component in the function of the E1A N-terminus.
Discussion
The present work implies that recruitment of TRRAP is required for oncogenic transformation by both cMyc and E1A oncoproteins. When tethered to the DNA binding domain of Myc, a small N-terminal domain of E1A (residues 12 ± 54) can functionally replace the Myc N-terminal transformation domain (residues 1 ± 262). Similar to the Myc N-terminal domain (McMahon et al., 1998) , E1A(12 ± 54) is necessary and sucient for TRRAP binding. Within E1A 12 ± 54, deletion of residues 26 ± 35 eliminates TRRAP binding and inhibits cellular transformation by both E1A ± Myc and E1A. Furthermore, overexpression of a TRRAP fragment (T3: residues 1360 ± 2260) that binds E1A 12 ± 54, and blocks interaction of E1A ± Myc and E1A with cellular TRRAP, abrogates oncogenic transformation. Our data thus demonstrate that in addition to disrupting Rb and p300 functions (Whyte et al., 1989) , recruitment of TRRAP is required for ecient cell transformation by the E1A protein.
A role of TRRAP in growth control is indicated by our data and previous functional studies. The mutant E1A D26 ± 35 is defective not only in cellular transformation and immortalization (this work), but also in deregulation of contact-inhibition (Dorsman et al., 1995) and cell cycle control . In particular, 12S E1A but not D26 ± 35 can prevent cell cycle arrest by the CDK2 inhibitor p27, and does so without reactivation of CDK2. Since E1A D26 ± 35 still can associate with pRb and prevent arrest by the CDK4 inhibitor p16, it is possible that residues 26 ± 35 of E1A target a cellular protein(s) that acts downstream of CDK2 in cell cycle control. These observations are consistent with our ®ndings that the TRRAP binding region of E1A is required for high eciency Ras-cotransformation and for immortalization.
Another cellular E1A binding protein, termed p400, whose E1A contact overlaps residues 12 ± 35 (Barbeau et al., 1994; Lillie et al., 1987) , and thus the TRRAP binding region, has recently been identi®ed. The p400 protein is related to SWI2/SNF2 and forms a complex with TRRAP and other proteins (Fuchs et al., 2001) . Expression of p400 protein fragments stimulates cell transformation by E1A and Ras independent of p400 ± E1A interaction (Fuchs et al., 2001 ). Here we show that expression of an E1A-binding TRRAP fragment severely inhibits E1A+Ras transformation, while REFs were stably co-transfected with Ha-Ras and the indicated constructs. Western blots: (a lanes 1 ± 3), (b lanes 1 ± 4) and (d lanes 1 ± 3): 100 mg of total cell proteins were resolved on 8% SDS ± PAGE, transferred on to PVDF membrane and probed with TRRAP ± NT, anti-Myc (9E10) or anti-E1A antibodies as indicated. Immunoprecipitations: (a lanes 4 ± 9), (b lanes 5 ± 8) and (d lanes 4 ± 7): 500 mg of total cell proteins were immunoprecipitated with TRRAP ± NT in RIPA or low detergent buer (Tween) as indicated, separated on an 8% SDS ± PAGE, transferred to PVDF and probed with the antibodies indicated. Arrows identify the various Myc, E1A ± Myc and E1A proteins. (c) Sepharose-coupled E1A(12 ± 54)-speci®c peptide binds cellular TRRAP. The E1A (12 ± 54) peptide and a control peptide, E1A (12 ± 54 S26 ± 35), in which residues 26 ± 35 were randomly scrambled were incubated with lysates from REFs in low detergent buer (Tween; lanes 2 and 4) or in RIPA (lanes 3 and 5). Proteins bound to the peptides were analysed by Western blot. Total cell extracts (lane 1) or bound proteins (lanes 2 to 5) were resolved on an 8% SDS ± PAGE, transferred on a PVDF membrane and probed with TRRAP ± NT blocking the interaction between E1A and the endogenous full-length TRRAP protein in the same cells (see Figure 3) , directly indicating the relevance of the E1A ± TRRAP and/or E1A ± TRRAP ± p400 interaction in cell transformation.
In addition to its presence in p400-containing complexes, TRRAP is also a subunit of the HAT Figure 3 TRRAP fragment T3 (aa1360 ± 2260) competes with the binding of E1A ± Myc and E1A to cellular TRRAP and interferes with cell transformation. (a) REFs were co-transfected with E1A ± Myc or E1A and Ras in conjunction with increasing concentrations (0 ± 4 mg) of TRRAP fragments (T1 ± T5) in pcDNA3 as described in Materials and methods. The total amount of transfected DNA was kept constant at 10 mg by compensation with empty pcDNA3. The number of transformed foci and puromycin-resistant colonies were quantitated and expressed as a percentage of the foci or puromycin-resistant colonies obtained with Ha-Ras and E1A (12 ± 54) ± Myc or E1A, respectively. The results of three independent experiments are presented with a variation less than 12% among the three independent experiments. REFs were stably co-transfected with E1A(12 ± 54) ± Myc (b) or E1A (c), activated Ha-Ras, empty pcDNA3 (panel B, lane 1) or each of the ®ve TRRAP fragments (panel B, lane 2 to 6 and panel C, lane 1 ± 5). Total cell extracts were prepared. For Western analysis 100 mg of cellular proteins from each transfection were resolved on 8% SDS ± PAGE, transferred to PVDF and probed with the antibodies indicated on the right of the panels. When indicated, 500 mg of total cell proteins were immunoprecipitated with TRRAP ± NT or anti-Hae antibodies. Immunoprecipitates were analysed as indicated above Figure 4 Amino-acids 26 ± 35 of E1A are necessary for transformation and immortalization. (a) REFs were co-transfected with Ras, E1A and control constructs as described in Materials and methods. Transfection eciencies were found to be similar within a given experiment as determined by the number of puromycin-resistant colonies. The experiments were carried out in triplicate. (b) REFs were stably transfected with E1A, E1AD26 ± 35 or the empty pBabe Hygro vector in the presence of a puromycin resistance marker. Drug-resistant cells were selected and then cultured for a total of 21 days. On day 0, 1610 4 cells/ well were seeded. Cells were counted every 7 days and the cumulative cell number was determined complex GCN5/SAGA that is required for Myc activity (Brand et al., 1999; McMahon et al., 2000) , but lacks p400 (Fuchs et al., 2001) . As Myc (McMahon et al., 1998) , E1A ± Myc and E1A (see Figure 3) have an analogous requirement for TRRAP interaction, E1A may functionally modulate both TRRAP ± p400 and TRRAP ± GCN5/SAGA complexes.
Materials and methods

Cell culture, transfection and transformation assays
Rat Embryo Fibroblasts (REFs) were prepared, cultured and transfected as described previously (Land, 1995) . Cotransfections were carried out with 5 mg of pUC ± Ha-Ras (Land et al., 1983) , 5 mg of the pBJ4 ± E1A ± Myc chimeras or 5 mg of pBabe Hygro E1A and 1 mg of pJ6 omega Puro. Control transfections contained the corresponding amounts of the respective empty vectors (Morgenstern and Land, 1990a,b) . It is noteworthy that upon transfection pBabe plasmids only promote relatively poor levels of protein expression. TRRAP fragments corresponding to TRRAP aa 1 ± 676 (T1), aa 676 ± 1383 (T2), aa 1351 ± 2275 (T3), aa 2252 ± 3039 (T4) and aa 3014 ± 3830 (T5) were cloned by PCR in pcDNA3. In transfections with pcDNA3 containing TRRAP fragments (3 mg) the amount of the co-transfected plasmids was reduced to 2 mg each. Focus formation and the outgrowth of 2.5 mg/ml puromycin-resistant colonies were monitored in parallel cultures. The immortalizing activity of E1A and the mutant derivative was measured by pooling puromycin-resistant cells followed by seeding 10 4 cells in a well of a 12-well dish. Cell numbers were determined each week. Upon reaching con¯uency cells were further diluted 1 : 5 and the cumulative cell number was determined.
Immunoprecipitation and immunoblots
TRRAP ± NT anti-serum was generated by immunization of rabbits with a synthetic peptide corresponding to amino-acids 368 to 394 of TRRAP, coupled to Keyhole limpet hemocyanin (KLH) (Hancock et al., 1998) . For immunoprecipitations, total cellular protein (500 mg) was incubated with the TRRAP antibody coupled to Protein G sepharose (Sigma) in 1 ml of RIPA (50 mm Tris HCl pH 7.5, 150 mm NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) or low detergent buer (50 mm HEPES pH 7.2, 150 mm NaCl, 1 mm EDTA, 0.1% NP40) for 2 h at 48C. Total proteins or immunoprecipitated proteins were resolved on 8% SDS ± PAGE gels and transferred to Immobilon P membranes (Millipore). Membranes were blocked in Phosphate buered saline (PBS) containing 5% dry milk and 1% sodium casein (USB) for 1 h at room temperature. Primary antibodies were used at 1 : 1000 (TRRAP ± NT) or 1 : 250 dilution (anti-E1A
[M29] and anti-Myc [9E10]) in 5% milk/1% sodium casein/ PBS. Secondary horseradish peroxidase-conjugated goat antimouse and goat anti-rabbit antibodies were used at 1 : 10 000 dilution. All incubations were carried out for 1 h at room temperature and were followed by three washes with PBS-0.1% Tween. Blots were developed using the ECL reagent (Amersham).
Coupling of peptides
Two mg of synthetic peptides corresponding to amino acids 12 ± 54 of E1A or containing random substitutions at amino acids 26 to 35 (S26 ± 35) were covalently bound to NHS activated sepharose beads according to manufacturer's instructions (Pharmacia). Cell extracts (1 mg protein) prepared from REF cells were incubated with the bead-bound peptides in 1 ml of low detergent buer or RIPA for 3 h at 48C. Proteins bound to the bead-coupled peptides were analysed by Western blotting and detected with TRRAP ± NT antiserum.
